Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides
More topics under "C07K - Peptides" (616,656)
C07K 1 - General processes for the preparation of peptides (51,718)
C07K 11 - Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof (895)
C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
C07K 19 - Hybrid peptides (29,428)
C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723)
C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102)
C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306)
Patents for C07K - Peptides (3,738)
12/2003
12/17/2003CN1131309C IL-6 mutein
12/11/2003WO2000070054A9 Pathogen-resistant grape plants
12/11/2003US20030229202 Comprises fusion protein for intracelluar delivery of compounds of interest into cells; drug delivery
12/11/2003US20030229021 Antiallergens
12/11/2003US20030229020 Vaccine; induce immunology response; administering monoclonal antibodies
12/11/2003US20030228652 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
12/09/2003US6660843 Fusion of Fc domains with biologically active peptides
12/04/2003US20030224487 Novel cytokine zcytor17 ligand
12/04/2003US20030224015 Administering to a mammal an immunogenic formulation containing an Ebola peptide, to induce a protective cytotoxic T lymphocyte response
12/03/2003EP1366075A2 New interferon beta-like molecules
12/03/2003CN1129796C Medicine box for detecting hepatitis virus C and use thereof
11/2003
11/27/2003WO2003097666A2 Use of gastrin releasing peptide (grp) and its receptor in cancer screening
11/27/2003WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
11/27/2003US20030219734 Calibrating immunoassay which detects natriuretic peptides for accurate diagnosis and prognosis of stroke, congestive heart failure, hypertensive, cardiovascular and nervous system disorders
11/27/2003US20030219403 Compositions and methods of tolerizing a primate to an antigen
11/26/2003EP1364967A2 Glucagon-like insulinotropic peptides, compositions and methods
11/26/2003EP1363664A2 Synthetic vaccine agents
11/20/2003WO2003095473A2 Peptides and methods for cell death regulation
11/20/2003WO2003094835A2 Fgf variants and methods for use thereof
11/20/2003US20030215542 Reduction of cystine containing polypeptides such as gliadins, glutenins, albumin or globulins, using thioredoxin or transferase enzymes; deactivation of neurotoxins
11/20/2003US20030215457 Comprising a nucleic acid, a polypeptide encoded by the nucleic acid, and a compound, preferably an antibody or fragment thereof, that binds to the polypeptide, preferably binding to the extracellular domain of LIV-1 polypeptide
11/20/2003CA2823041A1 Fgf variants and methods for use thereof
11/20/2003CA2483602A1 Fgf variants and methods for use thereof
11/13/2003US20030211597 Genetically engineered hepatitis C viral (HVC) particle for use in prevention, diagnosis and prognostication of viral infections; immunoassays; genetic vaccines diagnosis
11/13/2003US20030211457 Methods and kits for testing mutagenicity
11/13/2003US20030211100 Gene therapy; nucleic acid coding immunoglobulins; anticancer agents
11/12/2003CN1127510C Prodrugs of thrombin inhibitors
11/12/2003CN1127350C Cyclosorin-containing soft capsule preparations
11/11/2003US6645492 For diagnosis and therapy of susceptibility to atopic allergy, asthma
11/11/2003US6645484 Endothelial cell transmembrane tyrosine kinase ligand
11/06/2003WO2002018369A8 Peptidomimetic protease inhibitors
11/06/2003US20030208045 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM)
11/05/2003EP1359159A2 Analogues of GLP-1
11/05/2003EP1358213A2 Humanized antibodies that recognize beta amyloid peptide
11/05/2003EP1358209A2 Crystallization of igf-1
11/05/2003EP1358206A2 Peptide-based compounds
11/05/2003EP0777679B1 Delivery of nucleic acids
11/05/2003CN1126755C Process for preparing N-[5-(diphenyl phosphinyl methyl)-4-(4-fluoropheyl)-6-isopropyl pyrimidine-2-group]-N-methl methane sulfamide
10/2003
10/30/2003WO2002002638A3 Methods for treating rheumatic diseases using a soluble ctla4 molecule
10/30/2003US20030204049 Which have affinity/targeting vector for integrin receptors; diagnostic imaging
10/29/2003CN1452659A Corynebacterium glutamicum genes encoding metabolic pathway proteins
10/29/2003CN1125877C Hepatitis G. Virus and molecular cloning thereof
10/23/2003WO2003087123A2 Methods and kits for testing mutagenicity
10/23/2003WO2003086459A1 Methods of treatement using ctla-4 antibodies
10/23/2003US20030199561 Boronic ester and acid compounds, synthesis and uses
10/23/2003US20030198649 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
10/23/2003CA2481207A1 Methods of treatment using ctla-4 antibodies
10/22/2003EP1354029A2 Foggy
10/22/2003EP1353952A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
10/22/2003EP1353950A2 Method and apparatus for the production of antigens and uses thereof
10/22/2003CN1451014A Peptidomimetic protease inhibitors
10/22/2003CN1125174C Recombinant phages
10/21/2003CA2182289C Immuno-stimulatory monoclonal antibodies
10/16/2003WO2003084995A2 Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
10/16/2003CA2480598A1 Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
10/15/2003EP1352063A2 Receptor nucleic acids and polypeptides
10/09/2003WO2003040170A3 Antibodies to cd40
10/09/2003WO2002077017A3 Medical uses of intercellular communication facilitating compounds
10/09/2003US20030191063 Peptide selection method
10/09/2003US20030190740 Protease and peptidase-resistant proteins; Drug screening for control of cell division, apoptosis; for cancer treatment
10/08/2003CN1447817A Method for producing peptide salts. their use, and pharmaceutical prepns. containing these peptide salts
10/02/2003US20030186873 DNA sequences that codes for biological receptors involved in signal transduction, used for prophylaxis of inflammation and immunology related diseases and/or disorders
10/02/2003US20030186343 Immunoglobulin which binds low density lipoprotein receptor for diagnosis, prevention or treatment of viral infections; viricides
10/02/2003US20030185791 TNF-derived peptides for use in treating oedema
10/01/2003CN1446104A Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
09/2003
09/30/2003US6627415 Isolated nucleic acid comprising a nucleotide sequence encoding fibrinogen-like domain; use in diagnosis and treatment of tumor angiogenesis, wound healing, thromboembolic diseases, atherosclerosis and inflammationinflammation
09/30/2003US6627202 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
09/24/2003CN1444661A Method for detecting growth hormone variations in humans, the variations and their uses
09/23/2003CA2085781C Bradykinin-antagonists for the treatment of acute pancreatitis
09/18/2003WO2003076898A2 Mycobacterial diagnostics
09/18/2003US20030176647 Antibodies to OCIF-binding molecules
09/18/2003US20030175725 Mycobacterial diagnostics
09/16/2003US6620847 Copolymer-1 improvements in compositions of copolymers
09/16/2003CA2119463C Glial cell line-derived neutrophic factor
09/10/2003EP1342795A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/10/2003CN1441810A Soluble CTL A4 mutant molecules and use thereof
09/09/2003US6617317 Boronic ester and acid compositions
09/04/2003WO2002046237A3 Humanized antibodies that recognize beta amyloid peptide
09/04/2003US20030165496 Alzheimer's disease
09/03/2003EP1340821A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/03/2003EP1340820A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
08/2003
08/21/2003WO2003044056A3 Chemically-modified human growth hormone conjugates
08/21/2003US20030158375 Neutrophil stimulant; granulocyte colony stimulating factor; genetic engineering
08/20/2003CN1118571C Active protein with thrombopoietin
08/19/2003CA2138258C Synthetic peptides for the treatment of myasthenia gravis
08/14/2003WO2002038601A3 Foggy
08/14/2003US20030152940 Vectors comprise avian lysozyme leader peptide for targetting the endoplasmic reticulum; heparin affinity chromatography
08/13/2003CN1436195A Integrin binding peptide derivatives
08/12/2003US6605280 Interleukin-18 binding proteins, their preparation and use for blocking the activity of IL-18
08/07/2003US20030147909 Protein naturally obtained through the activation of the immune system of fish inoculated with the pathogen; for aquaculture
08/06/2003CN1434832A DNA for encoding the RGI polypeptide
08/05/2003US6602508 Method of immunization using a Group B Streptococcus type II and type III polysaccharide conjugate vaccine
07/2003
07/31/2003WO2003062279A1 Nutraceuticals for the treatment, protection and restoration of connective tissues
07/31/2003WO2002064627A3 Crystallization of igf-1
07/31/2003WO2002024909A3 Receptor nucleic acids and polypeptides
07/31/2003CA2474269A1 Nutraceuticals for the treatment, protection and restoration of connective tissues
07/29/2003CA2069481C Purified igc immunoglobulins
07/24/2003WO2003060090A2 Novel cytokine zcytor17 ligand
07/23/2003EP1329458A2 Peptides that lower blood glucose levels
07/23/2003EP0586607B1 HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 38